Federation des caisses Desjardins du Quebec’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,000
| Closed | -$20.5K | – | 2623 |
|
|
2022
Q1 | $20.5K | Hold |
5,000
| – | – | ﹤0.01% | 1816 |
|
|
2021
Q4 | $17.9K | Sell |
5,000
-600
| -11% | -$2.1K | ﹤0.01% | 1870 |
|
|
2021
Q3 | $20.4K | Hold |
5,600
| – | – | ﹤0.01% | 1849 |
|
|
2021
Q2 | $24.4K | Hold |
5,600
| – | – | ﹤0.01% | 1799 |
|
|
2021
Q1 | $23K | Hold |
5,600
| – | – | ﹤0.01% | 1769 |
|
|
2020
Q4 | $22.3K | Hold |
5,600
| – | – | ﹤0.01% | 1716 |
|
|
2020
Q3 | $15.1K | Hold |
5,600
| – | – | ﹤0.01% | 1570 |
|
|
2020
Q2 | $15.4K | Buy |
5,600
+600
| +12% | +$1.67K | ﹤0.01% | 1507 |
|
|
2020
Q1 | $11.8K | Hold |
5,000
| – | – | ﹤0.01% | 1629 |
|
|
2019
Q4 | $23.5K | Hold |
5,000
| – | – | ﹤0.01% | 1696 |
|
|
2019
Q3 | $16.7K | Hold |
5,000
| – | – | ﹤0.01% | 1710 |
|
|
2019
Q2 | $16.4K | Hold |
5,000
| – | – | ﹤0.01% | 1729 |
|
|
2019
Q1 | $15.2K | Hold |
5,000
| – | – | ﹤0.01% | 1572 |
|
|
2018
Q4 | $13.6K | Sell |
5,000
-180
| -3% | -$593 | ﹤0.01% | 1561 |
|
|
2018
Q3 | $17.4K | Hold |
5,180
| – | – | ﹤0.01% | 1593 |
|
|
2018
Q2 | $13.4K | Hold |
5,180
| – | – | ﹤0.01% | 1678 |
|
|
2018
Q1 | $11.4K | Hold |
5,180
| – | – | ﹤0.01% | 1681 |
|
|
2017
Q4 | $10.3K | Hold |
5,180
| – | – | ﹤0.01% | 1708 |
|
|
2017
Q3 | $16.8K | Hold |
5,180
| – | – | ﹤0.01% | 1568 |
|
|
2017
Q2 | $16.7K | Hold |
5,180
| – | – | ﹤0.01% | 1618 |
|
|
2017
Q1 | $14.7K | Buy |
+5,180
| New | +$12.5K | ﹤0.01% | 1356 |
|
Other funds holding ATRS
Federation des caisses Desjardins du Quebec's ATRS Position: Q2 2022 in Review
Federation des caisses Desjardins du Quebec sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 5,000 shares — an estimated $20.5K sold.
Federation des caisses Desjardins du Quebec first reported a position in ATRS in Q1 2017 and held it in 21 quarters. The position peaked at $24.4K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Federation des caisses Desjardins du Quebec reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 5,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $20.5K.
- Federation des caisses Desjardins du Quebec first reported a position in Antares Pharma, Inc. in Q1 2017 and held it in 21 quarters.
- Federation des caisses Desjardins du Quebec's Antares Pharma, Inc. position peaked at $24.4K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2022, filed 15 Aug 2024.